Published in Ann Surg Oncol on September 01, 1998
Tumor marker usage and medical care costs among older early-stage breast cancer survivors. J Clin Oncol (2014) 1.52
Patient's needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer (2004) 1.30
Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review. Eur Radiol (2011) 0.85
Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst (2014) 0.82
Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors. Springerplus (2015) 0.78
Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis. Curr Oncol (2012) 0.77
First indicators of relapse in breast cancer: evaluation of the follow-up program at our hospital. Int J Clin Oncol (2012) 0.77
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis. J Comp Eff Res (2013) 0.77
The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis. Biomed Res Int (2015) 0.75
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer. Cancer Res Treat (2015) 0.75
Follow-up after treatment of primary breast cancer. Ann Surg Oncol (1999) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
The uncertainty principle and industry-sponsored research. Lancet (2000) 7.75
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature (1988) 6.35
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer (2010) 4.95
Environmental tobacco smoke and lung cancer risk in nonsmoking women. J Natl Cancer Inst (1992) 4.19
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Comorbidity and functional status are independent in older cancer patients. J Clin Oncol (1998) 4.11
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene (2001) 3.96
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer (2006) 3.78
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr (1997) 3.29
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A (1988) 3.23
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost (2007) 3.22
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
A national telepathology trial in Sweden feasibility and assessment. Arch Anat Cytol Pathol (1995) 2.68
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29
Methodological challenges in the evaluation of prognostic factors in breast cancer. Breast Cancer Res Treat (1998) 2.28
Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol (1998) 2.27
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia. Transfusion (1993) 2.04
Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med (1997) 2.03
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
Bacteriologic and pharmacodynamic aspects of nalidixic acid. J Urol (1970) 1.95
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage (1999) 1.89
Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem (1997) 1.83
Abdominal obesity and breast cancer risk. Ann Intern Med (1990) 1.83
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med (2001) 1.74
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. MedGenMed (2000) 1.71
Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol (1999) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol (2001) 1.66
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg (1991) 1.61
Membrane action of DMSO and other chemical inducers of Friend leukaemic cell differentiation. Nature (1976) 1.59
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Rings of anionic amino acids as structural determinants of ion selectivity in the acetylcholine receptor channel. Proc Biol Sci (1991) 1.59
Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology (1998) 1.57
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54
Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res (1981) 1.54
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50
Prevention of postoperative pericardial adhesions by closure of the pericardium with absorbable polymer patches. An experimental study. J Thorac Cardiovasc Surg (1992) 1.50
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46
Obesity and body fat distribution and breast cancer prognosis. Cancer (1991) 1.46
Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1998) 1.46
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity. Am J Obstet Gynecol (1998) 1.43
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol (1995) 1.42
Characterization of a plasma retinol-binding protein membrane receptor expressed in the retinal pigment epithelium. J Biol Chem (1992) 1.41
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost (2014) 1.39
Screening mammography in the Tampa Bay area: current status and implications for the next decade. J Fla Med Assoc (1989) 1.39
Arterial hypotension and hypoxaemia during total hip replacement: the importance of thromboplastic products, fat embolism and acrylic monomers. Acta Anaesthesiol Scand (1975) 1.39
Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol (1998) 1.38
Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38
Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of nonpalpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol (2001) 1.38
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35
Quality of life after adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (2000) 1.33
Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol (2000) 1.31
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
The urethra and its relationship to urinary tract infection. II. The urethral flora of the female with recurrent urinary infection. J Urol (1968) 1.29
Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash) (2001) 1.28
Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg (2001) 1.28
Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash) (2001) 1.27
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
Gentamicin. Med Clin North Am (1970) 1.27
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery (2001) 1.26
An overview of evolution, systematics, population biology, cytogenetics, molecular biology and speciation in Ctenomys. Prog Clin Biol Res (1990) 1.25
Recurrence and progression in low grade papillary urothelial tumors. J Urol (1999) 1.25
The urethra and its relationship to urinary tract infection: the flora of the normal female urethra. South Med J (1966) 1.22
NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park) (2000) 1.22
Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides. Biochemistry (1980) 1.20
Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head Neck Surg (1987) 1.17
Significant expression of IGFBP2 in breast cancer compared with benign lesions. J Clin Pathol (2005) 1.16
Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. J Clin Invest (1982) 1.16
Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab Invest (1982) 1.16
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg (1994) 1.15